Also trades as: 4107.T (JPX) · $vol 8M
ICHMF OTC
ISE Chemicals Corporation
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +658.6%
1Y: +1142.7%
3Y: +2148.2%
$24.73
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$33.3B
+26.0% ▲
5Y CAGR: +14.6%
Gross Profit
$10.1B
+36.9% ▲
5Y CAGR: +22.8%
Operating Income
$7.7B
+44.6% ▲
5Y CAGR: +30.1%
Net Income
$5.1B
+38.1% ▲
5Y CAGR: +33.6%
EPS (Diluted)
$995.18
+38.1% ▲
5Y CAGR: +235.5%
EBITDA
$9.4B
+30.9% ▲
5Y CAGR: +24.3%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $16.9B | $20.4B | $25.6B | $26.4B | $33.3B |
| YoY Growth | +0.0% | +20.7% | +25.6% | +3.3% | +26.0% |
| Cost of Revenue | $13.1B | $15.9B | $19.9B | $19.0B | $23.2B |
| Gross Profit | $3.8B | $4.4B | $5.7B | $7.4B | $10.1B |
| Gross Margin | 22.5% | 21.9% | 22.2% | 28.0% | 30.4% |
| R&D Expenses | $248M | $264M | $260M | $260M | $0 |
| SG&A Expenses | $1.3B | $1.4B | $1.6B | $1.8B | $2.1B |
| Operating Expenses | $1.6B | $1.7B | $1.9B | $2.1B | $2.5B |
| Operating Income | $2.2B | $2.7B | $3.8B | $5.3B | $7.7B |
| Operating Margin | 13.0% | 13.3% | 14.7% | 20.1% | 23.0% |
| Interest Expense | $1M | $1M | $1M | $1M | $2M |
| Income Before Tax | $2.0B | $2.6B | $3.6B | $5.2B | $7.4B |
| Tax Expense | $645M | $818M | $1.0B | $1.5B | $2.3B |
| Net Income | $1.3B | $1.8B | $2.6B | $3.7B | $5.1B |
| Net Margin | 8.0% | 8.7% | 10.0% | 13.9% | 15.2% |
| EPS (Diluted) | $2.64 | $347.94 | $502.73 | $720.48 | $995.18 |
| EBITDA | $3.5B | $4.2B | $5.6B | $7.2B | $9.4B |
| Shares Outstanding | 510M | 510M | 510M | 510M | 510M |